{
    "organizations": [],
    "uuid": "dff249ee71a021152a2b4d801c007ed04e2c0643",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-five-prime-announces-pricing-of-up/brief-five-prime-announces-pricing-of-upsized-public-offering-of-common-stock-idUSASB0C2C2",
    "ord_in_thread": 0,
    "title": "BRIEF-Five Prime Announces Pricing Of Upsized Public Offering Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 25 (Reuters) - Five Prime Therapeutics Inc:\n* FIVE PRIME ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF COMMON STOCK\n* FIVE PRIME THERAPEUTICS - PRICED UNDERWRITTEN PUBLIC OFFERING OF 5.1 MILLION SHARES OF COMMON STOCK AT $19.50/SHARE​\n* FIVE PRIME THERAPEUTICS INC - ‍SIZE OF OFFERING WAS UPSIZED FROM $75 MILLION TO $100 MILLION​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-25T21:30:00.000+02:00",
    "crawled": "2018-01-26T21:08:49.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "five",
        "prime",
        "therapeutic",
        "inc",
        "five",
        "prime",
        "announces",
        "pricing",
        "upsized",
        "public",
        "offering",
        "common",
        "stock",
        "five",
        "prime",
        "therapeutic",
        "priced",
        "underwritten",
        "public",
        "offering",
        "million",
        "share",
        "common",
        "stock",
        "five",
        "prime",
        "therapeutic",
        "inc",
        "offering",
        "upsized",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}